期刊文献+

天花粉蛋白诱导NB4人白血病细胞凋亡研究 被引量:7

Study on NB4 Cell Apoptosis Induced by Trichosanthin
下载PDF
导出
摘要 为了研究单链核糖体失活蛋白天花粉蛋白(trichosanthin,TCS)诱导人类白血病细胞株NB4细胞的凋亡 及增长抑制的影响,采用流式细胞术分析NB4细胞经TCS诱导后细胞膜联蛋白V(annexinV)表达及线粒体膜电 位(△ψm)的改变;用MTT比色法测定TCS对NB4细胞的增长抑制率,用琼脂糖凝胶电泳做细胞凋亡DNA分析。 结果表明:①TCS时NB4细胞具有明显的增长抑制作用,并随TCS浓度的升高及作用时间的延长,抑制现象愈加 显著;②NB4细胞经TCS诱导后,annexin V呈阳性表达,随作用时间延长阳性率进一步升高;③线粒体△ψm随着 凋亡细胞的增加而逐渐降低;④DNA电泳呈梯状条带,表明TCS对NB4细胞确实存在诱导凋亡作用。结论:天花 粉蛋白在体外能够明显抑制NB4细胞的增长,并诱导细胞凋亡,为今后TCS应用于急性早幼粒白血病的临床治疗 提供重要的实验依据。 In order to study the influence of trichosanthin (TCS) on apoptosis and growth inhibition of human NB4 cells in vitro, the expression of annexin V and the change of △ψm of NB4 cells induced by TCS was analyzed by FACS, and MTT assay was adopted to measure the growth inhibition ratio of NB4 cells treated with TCS. Apoptosis was assayed by agarose gel eletrophoresis. The results showed the higher concentration of TCS and the longer the acting time, the stronger growth inhabition of NB4 cells. The expression of annexin V was positive, and the positive ratio was greatly enhanced with prolongation of acting time. △ψm reduced gradually while the apoptosis cells increasing. DNA agarose gel eletrophoresis showed a gradient, which confirmed that TCS could induce NB4 cells apoptosis. In conclusion, taken together, data show that TCS can inhibite NB4 growth in vitro, and induce apoptosis. Experiment provides an important evidence for application of TCS in clinical treatment of acute promyelocytic leukemia.
出处 《中国实验血液学杂志》 CAS CSCD 2005年第2期278-281,共4页 Journal of Experimental Hematology
关键词 天花粉蛋白 NB4细胞 急性早幼粒细胞白血痛 细胞凋亡 trichosanthin protein NB4 cell APL cell apoptosis
  • 相关文献

参考文献6

二级参考文献24

  • 1毕黎琦,刘继文,宋怡.中药天花粉对免疫调节T细胞作用的研究[J].中国中西医结合杂志,1994,14(1):18-20. 被引量:15
  • 2苏旭,张迎春,刘建香,刘树铮.胸腺细胞体外培养对细胞凋亡和细胞周期进程的影响[J].白求恩医科大学学报,1995,21(5):447-448. 被引量:7
  • 3郭峰,刘小平,徐瑛.天花粉对小鼠艾氏腹水癌的疗效和对红细胞免疫功能的影响[J].中西医结合杂志,1989,9(7):418-420. 被引量:23
  • 4[1]Mossman T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays [J]. J Immunol Methods, 1983,65(1):55
  • 5[2]Markus R, Werner S. Clinical trials of agents that reverse multidrug resistance[J]. Cancer, 1993,72(12) :3553
  • 6[3]Kikuchi Y, Iwano Ⅰ, Sash H, et al. Restorative effects of calmoclulin antagonists on reduced cisplatin uptake by cisplatin-resistant human ovarian carcinoma cells [J]. Gynecol Oncol, 1990,39:199
  • 7[4]McClay E, Albright K, Jones J, et al. Tamoxifen delays the development of resistance to cisplatin in human malignancies[J]. (abstr. 3204)Procel. ASCO,1994,12:132
  • 8[5]Present CA, Kennedy PS, Wiseman C, et al. Verapamil reversal of clinical doxorubicin resistance in human cancer[J]. Br J Cancer, 1986,9(4) :355
  • 9[6]Ito Y, Kobayashi T, Takeda T, et al. Expression of P21 (WAF1 /cipl) protein in clinical thyroid tissues[J]. Br J Cancer, 1996,74:1269
  • 10[7]Zhang W, Grasso L, McClain CD, et al. P53-independent induction of WAF1 /cipl in human leukemia cells is correlated with rowth arrest accompanying monocyte macrophage differentiation[J]. Cancer Res, 1995,55: 668

共引文献95

同被引文献47

引证文献7

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部